Membrane oxygenator

Global Cardiopulmonary Oxygenator Market Set to Reach $926 Million by 2028, Driven by Aging Populations and Technological Advances - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 20, 2023
Biotechnology, General Health, Medical Devices, Health, Cardiology, United States Census Bureau, Prevalence, Diabetes, Membrane oxygenator, Hospital, Incidence, Heart, Element, Oxygen, Ageing, CABG, Obesity, Sterilization, Growth, Carbon, Patient, Safety, Intelligence, Application, Medical device

The global cardiopulmonary oxygenator market was valued at US$742.12 million in 2022.

Key Points: 
  • The global cardiopulmonary oxygenator market was valued at US$742.12 million in 2022.
  • The cardiopulmonary oxygenator market has grown in recent years due to technological advancements, demographic shifts, and expanding healthcare infrastructure.
  • These trends are likely to persist in the forthcoming years, driven by a commitment to innovation and an aging global population with increasing healthcare needs.
  • The key players in the global cardiopulmonary oxygenator market are:

Global Extracorporeal Membrane Oxygenation Machine Market Report 2021-2028 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 9, 2021
Hospitals, Health, Cardiology, Medicine, Medical equipment, Medical specialties, Medical terminology, Membrane technology, Clinical medicine, Intensive care medicine, Extracorporeal membrane oxygenation, Extracorporeal, Oxygenator, Oxygen saturation, Membrane oxygenator

The "Extracorporeal Membrane Oxygenation Machine Market Size, Share & Trends Analysis Report by Component (Oxygenator, Pumps), by Modality, by Patient Type, by Application, by Region, and Segment Forecasts, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Extracorporeal Membrane Oxygenation Machine Market Size, Share & Trends Analysis Report by Component (Oxygenator, Pumps), by Modality, by Patient Type, by Application, by Region, and Segment Forecasts, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.
  • The global extracorporeal membrane oxygenation machine market size is expected to reach USD 398.6 million by 2028.
  • The market is primarily driven by the increasing incidence of cardiopulmonary and respiratory diseases and technological advancement in the field of ECMO procedures.
  • The increasing survival rate of ECMO machine supported surgery for cardiac and respiratory patients is also augmenting the market growth.

FDA Grants 510(k) Clearance for Abiomed’s Innovative Cardiopulmonary Support Technology

Retrieved on: 
Monday, October 26, 2020
Medical devices, FDA, Health, Infectious diseases, Cardiology, Biotechnology, Medical equipment, Chemical compounds, Chemistry, Medicine, Membrane technology, Extracorporeal membrane oxygenation, Intensive care medicine, Cardiopulmonary bypass, Bypass, Abiomed, Carbon dioxide, Membrane oxygenator

The 510(k) clearance is to pump, oxygenate, and remove carbon dioxide from blood during cardiopulmonary bypass for up to six hours.

Key Points: 
  • The 510(k) clearance is to pump, oxygenate, and remove carbon dioxide from blood during cardiopulmonary bypass for up to six hours.
  • Abiomeds Breethe technology is a novel, easy-to-use cardiopulmonary bypass system that is designed for mobility.
  • As a leader in technology and innovation, the Breethe system is a natural addition to Abiomeds existing product portfolio, said Michael R. Minogue, Abiomeds Chairman, President and Chief Executive Officer.
  • This ECMO technology adds to Abiomeds innovative portfolio focused on native heart and lung recovery.

Medical Membrane Devices Markets and Technologies Report 2019: 2017-2018 Data & CAGR Projections, 2019-2023 - ResearchAndMarkets.com

Retrieved on: 
Monday, March 25, 2019
Health, Medical devices, Medicine, Membrane technology, Clinical medicine, Medical equipment, Natural sciences, Membrane oxygenator, Oxygenator, Medical device, Artificial kidney, Apheresis, Membrane

The "Medical Membrane Devices: Markets and Technologies" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Medical Membrane Devices: Markets and Technologies" report has been added to ResearchAndMarkets.com's offering.
  • This report involves medical membrane devices used in the medical device industry.
  • This report mainly deals with the medical membrane devices market covering the total market, which includes hemodialyzers, membrane oxygenators, intravenous infusion (IV) infusion filters, blood microfilters, and apheresis systems, and membrane diagnostic devices.
  • The report also covers the use of medical membrane devices for cardiopulmonary treatments, renal diseases, parenteral administration, and home care diagnosis.

Medical Membrane Devices: Markets and Technologies

Retrieved on: 
Monday, March 11, 2019
Medicine, Clinical medicine, Medical equipment, Membrane technology, Nephrology, Oxygenator, Membrane oxygenator, Apheresis, Medical procedure, Artificial kidney, Medical device

This report involves the medical membrane devices used in the medical device industry.This report mainly deals with the medical membrane devices market covering the total market, which includes hemodialyzers, membrane oxygenators, intravenous infusion (IV) infusion filters, blood microfilters and apheresis systems, and membrane diagnostic devices.

Key Points: 
  • This report involves the medical membrane devices used in the medical device industry.This report mainly deals with the medical membrane devices market covering the total market, which includes hemodialyzers, membrane oxygenators, intravenous infusion (IV) infusion filters, blood microfilters and apheresis systems, and membrane diagnostic devices.
  • The report also covers the use of medical membrane devices for cardiopulmonary treatments, renal diseases, parenteral administration and home care diagnosis.
  • Since then, medical membrane devices have found global acceptance in a wide variety of medical procedures, including cardiopulmonary treatments, renal diseases, parenteral administration and home-care diagnosis.
  • The medical membrane device market can be segmented broadly into hemodialyzers, membrane oxygenators, intravenous infusion filters, blood microfilters and apheresis systems, and membrane diagnostic devices.

Getinge Informs About a Voluntary Medical Device Recall for the QUADROX-i Neonatal Oxygenator

Retrieved on: 
Monday, November 26, 2018
Medical equipment, Medicine, Health, Oxygenator, Cardiopulmonary bypass, Cardiac surgery, Extracorporeal, Class I recall, Membrane oxygenator

Getinge is informing about a global voluntary Medical Device Recall for the QUADROX-i Neonatal Oxygenator.

Key Points: 
  • Getinge is informing about a global voluntary Medical Device Recall for the QUADROX-i Neonatal Oxygenator.
  • Getinge has reported to relevant competent authorities according to applicable regulations and does not expect the cost for the recall to be material.
  • The QUADROX-i Neonatal Oxygenator is intended for use in extracorporeal circulation during cardiopulmonary bypass in cardiac surgery for neonatal patients.
  • In the US, the recall affects 9 customers, and has been classified as a Class I recall by the FDA.